ID   SYSM_HUMAN              Reviewed;         518 AA.
AC   Q9NP81; A6NHW7; B4DE10; Q9BVP3;
DT   10-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   28-JUN-2023, entry version 191.
DE   RecName: Full=Serine--tRNA ligase, mitochondrial;
DE            EC=6.1.1.11;
DE   AltName: Full=SerRSmt;
DE   AltName: Full=Seryl-tRNA synthetase;
DE            Short=SerRS;
DE   AltName: Full=Seryl-tRNA(Ser/Sec) synthetase;
DE   Flags: Precursor;
GN   Name=SARS2; Synonyms=SARSM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10764807; DOI=10.1074/jbc.m908473199;
RA   Yokogawa T., Shimada N., Takeuchi N., Benkowski L., Suzuki T., Omori A.,
RA   Ueda T., Nishikawa K., Spremulli L.L., Watanabe K.;
RT   "Characterization and tRNA recognition of mammalian mitochondrial seryl-
RT   tRNA synthetase.";
RL   J. Biol. Chem. 275:19913-19920(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [7]
RP   VARIANT HUPRAS GLY-390.
RX   PubMed=21255763; DOI=10.1016/j.ajhg.2010.12.010;
RA   Belostotsky R., Ben-Shalom E., Rinat C., Becker-Cohen R., Feinstein S.,
RA   Zeligson S., Segel R., Elpeleg O., Nassar S., Frishberg Y.;
RT   "Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia,
RT   pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA
RT   syndrome.";
RL   Am. J. Hum. Genet. 88:193-200(2011).
CC   -!- FUNCTION: Catalyzes the attachment of serine to tRNA(Ser). Is also
CC       probably able to aminoacylate tRNA(Sec) with serine, to form the
CC       misacylated tRNA L-seryl-tRNA(Sec), which will be further converted
CC       into selenocysteinyl-tRNA(Sec). {ECO:0000250|UniProtKB:Q9N0F3}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-serine + tRNA(Ser) = AMP + diphosphate + H(+) + L-
CC         seryl-tRNA(Ser); Xref=Rhea:RHEA:12292, Rhea:RHEA-COMP:9669,
CC         Rhea:RHEA-COMP:9703, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:33384, ChEBI:CHEBI:78442,
CC         ChEBI:CHEBI:78533, ChEBI:CHEBI:456215; EC=6.1.1.11;
CC         Evidence={ECO:0000250|UniProtKB:Q9N0F3};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-serine + tRNA(Sec) = AMP + diphosphate + H(+) + L-
CC         seryl-tRNA(Sec); Xref=Rhea:RHEA:42580, Rhea:RHEA-COMP:9742,
CC         Rhea:RHEA-COMP:10128, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:33384, ChEBI:CHEBI:78442,
CC         ChEBI:CHEBI:78533, ChEBI:CHEBI:456215; EC=6.1.1.11;
CC         Evidence={ECO:0000250|UniProtKB:Q9N0F3};
CC   -!- PATHWAY: Aminoacyl-tRNA biosynthesis; selenocysteinyl-tRNA(Sec)
CC       biosynthesis; L-seryl-tRNA(Sec) from L-serine and tRNA(Sec): step 1/1.
CC   -!- SUBUNIT: Homodimer. The tRNA molecule probably binds across the dimer.
CC       {ECO:0000250|UniProtKB:Q9N0F3}.
CC   -!- INTERACTION:
CC       Q9NP81; Q96HA8: NTAQ1; NbExp=3; IntAct=EBI-1049768, EBI-741158;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000250|UniProtKB:Q9N0F3}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NP81-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NP81-2; Sequence=VSP_043020;
CC   -!- DOMAIN: Consists of two distinct domains, a catalytic core and a N-
CC       terminal extension that is involved in tRNA binding.
CC       {ECO:0000250|UniProtKB:Q9N0F3}.
CC   -!- DISEASE: Hyperuricemia, pulmonary hypertension, renal failure, and
CC       alkalosis syndrome (HUPRAS) [MIM:613845]: A multisystem disorder
CC       characterized by onset in infancy of progressive renal failure leading
CC       to electrolyte imbalances, metabolic alkalosis, pulmonary hypertension,
CC       hypotonia, and delayed development. Affected individuals are born
CC       prematurely. {ECO:0000269|PubMed:21255763}. Note=The disease is caused
CC       by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class-II aminoacyl-tRNA synthetase family.
CC       Type-1 seryl-tRNA synthetase subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH01020.2; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB029948; BAA99557.1; -; mRNA.
DR   EMBL; AK000457; BAA91176.1; -; mRNA.
DR   EMBL; AK293414; BAG56921.1; -; mRNA.
DR   EMBL; AC011455; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001020; AAH01020.2; ALT_INIT; mRNA.
DR   EMBL; BC042912; AAH42912.1; -; mRNA.
DR   CCDS; CCDS33017.1; -. [Q9NP81-1]
DR   CCDS; CCDS54265.1; -. [Q9NP81-2]
DR   RefSeq; NP_001139373.1; NM_001145901.1. [Q9NP81-2]
DR   RefSeq; NP_060297.1; NM_017827.3. [Q9NP81-1]
DR   PDB; 7TZB; X-ray; 2.95 A; A/B=35-518.
DR   PDB; 7U2A; EM; 4.10 A; A/B=1-518.
DR   PDB; 7U2B; EM; 4.10 A; A/B=1-518.
DR   PDB; 7YDF; X-ray; 2.80 A; A=181-518.
DR   PDB; 7YDG; X-ray; 3.20 A; A/B/C/D=181-518.
DR   PDBsum; 7TZB; -.
DR   PDBsum; 7U2A; -.
DR   PDBsum; 7U2B; -.
DR   PDBsum; 7YDF; -.
DR   PDBsum; 7YDG; -.
DR   AlphaFoldDB; Q9NP81; -.
DR   SMR; Q9NP81; -.
DR   BioGRID; 120278; 94.
DR   IntAct; Q9NP81; 33.
DR   MINT; Q9NP81; -.
DR   STRING; 9606.ENSP00000472847; -.
DR   GlyCosmos; Q9NP81; 1 site, 1 glycan.
DR   GlyGen; Q9NP81; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9NP81; -.
DR   PhosphoSitePlus; Q9NP81; -.
DR   SwissPalm; Q9NP81; -.
DR   BioMuta; SARS2; -.
DR   DMDM; 23822219; -.
DR   EPD; Q9NP81; -.
DR   jPOST; Q9NP81; -.
DR   MassIVE; Q9NP81; -.
DR   MaxQB; Q9NP81; -.
DR   PaxDb; Q9NP81; -.
DR   PeptideAtlas; Q9NP81; -.
DR   Antibodypedia; 30224; 149 antibodies from 26 providers.
DR   DNASU; 54938; -.
DR   Ensembl; ENST00000221431.11; ENSP00000221431.6; ENSG00000104835.15. [Q9NP81-1]
DR   Ensembl; ENST00000600042.5; ENSP00000472847.1; ENSG00000104835.15. [Q9NP81-2]
DR   Ensembl; ENST00000634687.3; ENSP00000489539.1; ENSG00000283104.3. [Q9NP81-1]
DR   Ensembl; ENST00000635245.1; ENSP00000489453.1; ENSG00000283104.3. [Q9NP81-2]
DR   GeneID; 54938; -.
DR   KEGG; hsa:54938; -.
DR   MANE-Select; ENST00000221431.11; ENSP00000221431.6; NM_017827.4; NP_060297.1.
DR   UCSC; uc002oka.3; human. [Q9NP81-1]
DR   AGR; HGNC:17697; -.
DR   CTD; 54938; -.
DR   DisGeNET; 54938; -.
DR   GeneCards; SARS2; -.
DR   HGNC; HGNC:17697; SARS2.
DR   HPA; ENSG00000104835; Low tissue specificity.
DR   MalaCards; SARS2; -.
DR   MIM; 612804; gene.
DR   MIM; 613845; phenotype.
DR   neXtProt; NX_Q9NP81; -.
DR   OpenTargets; ENSG00000104835; -.
DR   Orphanet; 363694; Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome.
DR   PharmGKB; PA134899753; -.
DR   VEuPathDB; HostDB:ENSG00000104835; -.
DR   eggNOG; KOG2509; Eukaryota.
DR   GeneTree; ENSGT00940000153792; -.
DR   HOGENOM; CLU_023797_4_1_1; -.
DR   InParanoid; Q9NP81; -.
DR   OrthoDB; 239638at2759; -.
DR   PhylomeDB; Q9NP81; -.
DR   BRENDA; 6.1.1.11; 2681.
DR   PathwayCommons; Q9NP81; -.
DR   Reactome; R-HSA-379726; Mitochondrial tRNA aminoacylation.
DR   SignaLink; Q9NP81; -.
DR   SIGNOR; Q9NP81; -.
DR   UniPathway; UPA00906; UER00895.
DR   BioGRID-ORCS; 54938; 477 hits in 1151 CRISPR screens.
DR   ChiTaRS; SARS2; human.
DR   GeneWiki; SARS2; -.
DR   GenomeRNAi; 54938; -.
DR   Pharos; Q9NP81; Tbio.
DR   PRO; PR:Q9NP81; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q9NP81; protein.
DR   Bgee; ENSG00000104835; Expressed in apex of heart and 93 other tissues.
DR   ExpressionAtlas; Q9NP81; baseline and differential.
DR   Genevisible; Q9NP81; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0004828; F:serine-tRNA ligase activity; ISS:UniProtKB.
DR   GO; GO:0000049; F:tRNA binding; IBA:GO_Central.
DR   GO; GO:0070158; P:mitochondrial seryl-tRNA aminoacylation; IBA:GO_Central.
DR   GO; GO:0006434; P:seryl-tRNA aminoacylation; ISS:UniProtKB.
DR   CDD; cd00770; SerRS_core; 1.
DR   Gene3D; 1.10.287.40; Serine-tRNA synthetase, tRNA binding domain; 1.
DR   InterPro; IPR002314; aa-tRNA-synt_IIb.
DR   InterPro; IPR006195; aa-tRNA-synth_II.
DR   InterPro; IPR045864; aa-tRNA-synth_II/BPL/LPL.
DR   InterPro; IPR002317; Ser-tRNA-ligase_type_1.
DR   InterPro; IPR042103; SerRS_1_N_sf.
DR   InterPro; IPR033729; SerRS_core.
DR   InterPro; IPR010978; tRNA-bd_arm.
DR   PANTHER; PTHR11778:SF7; SERINE--TRNA LIGASE, CYTOPLASMIC-RELATED; 1.
DR   PANTHER; PTHR11778; SERYL-TRNA SYNTHETASE; 1.
DR   Pfam; PF00587; tRNA-synt_2b; 1.
DR   PIRSF; PIRSF001529; Ser-tRNA-synth_IIa; 1.
DR   PRINTS; PR00981; TRNASYNTHSER.
DR   SUPFAM; SSF55681; Class II aaRS and biotin synthetases; 1.
DR   SUPFAM; SSF46589; tRNA-binding arm; 1.
DR   PROSITE; PS50862; AA_TRNA_LIGASE_II; 1.
DR   TIGRFAMs; TIGR00414; serS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Aminoacyl-tRNA synthetase;
KW   ATP-binding; Ligase; Mitochondrion; Nucleotide-binding;
KW   Protein biosynthesis; Reference proteome; Transit peptide.
FT   TRANSIT         1..34
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000250|UniProtKB:Q9N0F3"
FT   CHAIN           35..518
FT                   /note="Serine--tRNA ligase, mitochondrial"
FT                   /id="PRO_0000035822"
FT   REGION          498..518
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         299..301
FT                   /ligand="L-serine"
FT                   /ligand_id="ChEBI:CHEBI:33384"
FT                   /evidence="ECO:0000250|UniProtKB:Q9N0F3"
FT   BINDING         330..332
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9N0F3"
FT   BINDING         345
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9N0F3"
FT   BINDING         352
FT                   /ligand="L-serine"
FT                   /ligand_id="ChEBI:CHEBI:33384"
FT                   /evidence="ECO:0000250|UniProtKB:Q9N0F3"
FT   BINDING         418..421
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9N0F3"
FT   BINDING         453
FT                   /ligand="L-serine"
FT                   /ligand_id="ChEBI:CHEBI:33384"
FT                   /evidence="ECO:0000250|UniProtKB:Q9N0F3"
FT   MOD_RES         110
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JJL8"
FT   MOD_RES         195
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JJL8"
FT   VAR_SEQ         132..155
FT                   /note="DPKYQGLRARGREIRKELVHLYPR -> VRLDPGAGSIFGPTFLPFPGQLSL
FT                   LV (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043020"
FT   VARIANT         35
FT                   /note="T -> A (in dbSNP:rs34264048)"
FT                   /id="VAR_052645"
FT   VARIANT         83
FT                   /note="S -> L (in dbSNP:rs34050897)"
FT                   /id="VAR_052646"
FT   VARIANT         390
FT                   /note="D -> G (in HUPRAS; dbSNP:rs727502784)"
FT                   /evidence="ECO:0000269|PubMed:21255763"
FT                   /id="VAR_065820"
FT   STRAND          187..193
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   HELIX           205..211
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   STRAND          214..216
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   STRAND          230..232
FT                   /evidence="ECO:0007829|PDB:7YDG"
FT   HELIX           234..252
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   STRAND          256..258
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   HELIX           303..306
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   TURN            307..310
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   STRAND          311..313
FT                   /evidence="ECO:0007829|PDB:7YDG"
FT   HELIX           315..317
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   STRAND          319..329
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   STRAND          346..359
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   HELIX           360..381
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   STRAND          386..391
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   TURN            394..397
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   STRAND          401..410
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   TURN            411..414
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   STRAND          415..426
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   HELIX           427..433
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   STRAND          436..438
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   STRAND          440..442
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   STRAND          444..446
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   STRAND          448..456
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   HELIX           457..468
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   HELIX           479..485
FT                   /evidence="ECO:0007829|PDB:7YDF"
FT   STRAND          486..489
FT                   /evidence="ECO:0007829|PDB:7YDF"
SQ   SEQUENCE   518 AA;  58283 MW;  C6516A9527B34EB7 CRC64;
     MAASMARRLW PLLTRRGFRP RGGCISNDSP RRSFTTEKRN RNLLYEYARE GYSALPQLDI
     ERFCACPEEA AHALELRKGE LRSADLPAII STWQELRQLQ EQIRSLEEEK AAVTEAVRAL
     LANQDSGEVQ QDPKYQGLRA RGREIRKELV HLYPREAQLE EQFYLQALKL PNQTHPDVPV
     GDESQARVLH MVGDKPVFSF QPRGHLEIGE KLDIIRQKRL SHVSGHRSYY LRGAGALLQH
     GLVNFTFNKL LRRGFTPMTV PDLLRGAVFE GCGMTPNANP SQIYNIDPAR FKDLNLAGTA
     EVGLAGYFMD HTVAFRDLPV RMVCSSTCYR AETNTGQEPR GLYRVHHFTK VEMFGVTGPG
     LEQSSQLLEE FLSLQMEILT ELGLHFRVLD MPTQELGLPA YRKFDIEAWM PGRGRFGEVT
     SASNCTDFQS RRLHIMFQTE AGELQFAHTV NATACAVPRL LIALLESNQQ KDGSVLVPPA
     LQSYLGTDRI TAPTHVPLQY IGPNQPRKPG LPGQPAVS
//
